Bioc Stock Forecast Zacks
Should i buy biocept, inc. And has now fallen 5 days in a row.
Bioc | complete biocept inc.
Bioc stock forecast zacks. (bioc) stock quote, history, news and other vital information to help you with your stock trading and investing. Earnings for biocept are expected to decrease in the coming year, from ($0.09) to ($1.04) per share. Biocept inc (bioc) gets an overall rank of 54, which is an above average rank under investorsobserver's stock ranking system.
Get the latest detailed estimate from zacks investment research. Use the zacks rank and style scores to find out is bioc is right for your portfolio. The medical technology company reported ($0.02) earnings per share (eps) for the quarter, beating the zacks' consensus estimate of ($0.03) by $0.01.
This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. Learn more on bioc's analyst rating history This upgrade primarily reflects an upward trend in.
Biocept (bioc) could be a solid addition to your portfolio given its recent upgrade to a zacks rank #2 (buy). (nasdaq:bioc) announced its quarterly earnings results on monday, november, 15th. Biocept nasdaq updated nov 25, 2021 12:59 am.
Annual revenue (last year) $27.5m: Revenues of $4.06 billion outpaced the. By zacks equity research published on july 16,2018
Get the latest broker reports from zacks investment research. Bioc biocept — stock price and discussion | stocktwits. During the day the stock fluctuated 5.43% from a day low at $3.50 to a day high of $3.69.
Therefore, the zacks rating upgrade for biocept basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. According to the issued ratings of 3 analysts in the last year, the consensus rating for biocept stock is buy based on the current 3 buy ratings for bioc. The medical research company reported $0.03 earnings per share (eps) for the quarter, missing the zacks' consensus estimate of $0.09 by $0.06.
The price has fallen in 7 of the last 10 days and is down by. Bioc stock analysis overview what this means: Find the latest biocept, inc.
Stock adds 9.8% in session. Biocept (bioc) could be a solid addition to your portfolio given its recent upgrade to a zacks rank #2 (buy). In fact, when combining a zacks rank #3 or better and a positive earnings esp, stocks produced a positive surprise 70% of the time, while they also.
Biocept has not formally confirmed its next earnings publication date, but the company's estimated earnings date is monday, april 4th, 2022 based off prior year's report dates.
Post a Comment for "Bioc Stock Forecast Zacks"